Delivery Order SPE2DB20D9136-SPE2DB26FJ58D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of June 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its facility in Park Ridge, IL. This delivery order utilizes firm fixed-price pricing and was issued without a set-aside designation, allowing the contractor to compete...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of September 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The order will be performed at the contractor's Park Ridge facility and represents a specific product delivery under the company's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials, with a completion date of September 7, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of July 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order, reflecting the established pricing for this specific pharmaceutical product within the...
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order was issued without a set-aside designation, allowing the vendor to compete in the open market while leveraging its...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a continuation of DLA's pharmaceutical supply operations through its broader procurement...
- The Defense Logistics Agency awarded a $2,783.55 delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for YF-VAX 1 Dose Vials with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order carries no set-aside designation and is to be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, serves as the prime contractor and has been registered in the System for Award...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $5,634.90 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of YF-VAX 1 dose vials. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, which enables the agency to place orders for a broad range of...
- The Defense Logistics Agency issued a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 16, 2025, and was awarded on August 25, 2025, without any set-aside designation. This delivery order represents an individual procurement action issued under DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,817.45, is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of August 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
- SPE2DB20D9136Indefinite Delivery Contract
- SPE2DB20D9136-SPE2DB26FJ58DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of November 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a firm fixed-price contract type, with performance to be completed at the awardee's Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent contract enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products supporting medical supply needs across military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. The company's robust federal procurement portfolio demonstrates its capability to meet specialized pharmaceutical requirements for military health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 10/14/25 |